Twist Bioscience Corporation (TWST)
收市後：
| 前收市價 | 40.69 |
| 開市 | 41.14 |
| 買盤 | 40.77 x 200 |
| 賣出價 | 40.89 x 200 |
| 今日波幅 | 40.04 - 41.34 |
| 52 週波幅 | 14.42 - 50.50 |
| 成交量 | |
| 平均成交量 | 945,069 |
| 市值 | 2.377B |
| Beta 值 (5 年，每月) | 1.63 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.36 |
| 業績公佈日 | 2024年8月02日 - 2024年8月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 43.76 |
Investor's Business DailyIBD 50 Stock Reverses Badly As Weight-Loss Boost Fades Fast; Cathie Wood Stock Falls Hard
This online drug provider will offer an online weight loss drug but the stock sank soon after it jumped. A Cathie Wood biotech stock also gave back gains.
ZacksWhat Makes Twist Bioscience (TWST) a Strong Momentum Stock: Buy Now?
Does Twist Bioscience (TWST) have what it takes to be a top stock pick for momentum investors? Let's find out.
InvestorPlaceGenomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Genomics is the future of medicine. With it, companies are racing to shed light on human health and disease. Over the last two decades, related studies have allowed us to create genetic risk scores. For example, millions of people can get a better idea of developing a disease based on individual genetics. Also, this is creating big opportunity for some of the best genomics stock picks. “Genomics has given us a more comprehensive understanding of genetic risk factors for complex traits (body mass
